How NORE1A acts as a barrier to tumor growth

March 16, 2015, Rockefeller University Press
Activated Ras induces cell senescence (blue) are shown in the presence (left), but not the absence (right), of NORE1A. Credit: Clark Lab

Researchers reveal how cells protect themselves from a protein that is a key driver of cancer. The study appears in The Journal of Cell Biology.

Mutations that activate a protein called Ras drive excessive cell proliferation associated with cancer, but their ability to promote is limited by the fact that they also induce cells to exit the cell cycle and become dormant, or senescent. How active Ras mutants induce senescence, and how this pathway is disrupted in cancer cells is still unclear.

Geoffrey Clark and colleagues from the University of Louisville examined the role of the tumor suppressor NORE1A, a protein that binds to active Ras. Overexpressing NORE1A induced , whereas removing the protein prevented senescence and enhanced the transformation of cells with cancer-promoting Ras mutations.

The researchers found that Ras enhanced NORE1A's association with a kinase called HIPK2, and that this interaction was required for cell senescence. NORE1A promoted HIPK2's association with p53, a that plays a major role in restricting cancer development. HIPK2 is known to modify p53 in ways that cause either apoptosis, a kind of cell suicide, or senescence. Clark and colleagues found that NORE1A enhanced the senescence pathway.

The findings delineate how NORE1A allows Ras to modulate and induce cell senescence, and the loss of NORE1A may be a critical step in the growth of tumors.

Explore further: Restoring ability to halt cell division may protect lung cells from cancer

More information: Donninger, H., et al. 2015. J. Cell Biol. DOI: 10.1083/jcb.201408087

Related Stories

Restoring ability to halt cell division may protect lung cells from cancer

March 2, 2015
Researchers led by a team at the University of Illinois at Chicago, have identified a novel role for a signaling mechanism in lung cells that permanently places them into a state of suspended animation called senescence. ...

Tipping the balance between senescence and proliferation

November 15, 2013
An arrest in cell proliferation, also referred to as cellular senescence, occurs as a natural result of aging and in response to cellular stress. Senescent cells accumulate with age and are associated with many aging phenotypes, ...

Clipping proteins that package genes may limit abnormal cell growth in tumors

November 21, 2014
Changes to the structure of the protein histone H3.3 may play a key role in silencing genes that regulate cancer cell growth, according to a study led by researchers from the Icahn School of Medicine at Mount Sinai and published ...

A protein on which two molecular pathways converge could be the key to new cancer therapies

February 4, 2015
Two molecular pathways—one that causes cancer and one that protects against it—compete to control cellular levels of one protein, according to a new study by A*STAR researchers and colleagues.The finding highlights a ...

Recommended for you

Targeting the engine room of the cancer cell

June 18, 2018
Researchers at Columbia University Irving Medical Center (CUIMC) have developed a highly innovative computational framework that can support personalized cancer treatment by matching individual tumors with the drugs or drug ...

Researchers create novel combination as potential therapy for high-risk neuroblastoma

June 18, 2018
Researchers at VCU Massey Cancer Center in Richmond, Virginia, have identified a promising target to reverse the development of high-risk neuroblastoma and potentially inform the creation of novel combination therapies for ...

Study suggests well-known growth suppressor actually fuels lethal brain cancers

June 18, 2018
Scientists report finding a potentially promising treatment target for aggressive and deadly high-grade brain cancers like glioblastoma. But they also say the current lack of a drug that hits the molecular target keeps it ...

Genomics offers new treatment options for infants with range of soft tissue tumors

June 18, 2018
The genetic causes of a group of related infant cancers have been discovered by scientists at the Wellcome Sanger Institute, the University of Wuerzburg and their collaborators. Whole genome sequencing of tumours revealed ...

Standard myelofibrosis drug can awaken 'dormant' lymphoma

June 18, 2018
Most patients with myelofibrosis, a rare chronic disorder of the haematopoietic cells of the bone marrow, benefit from drugs from the JAK2 inhibitor class: symptoms are relieved, survival extended and general quality-of-life ...

Breast cancer researcher warns against online genetic tests

June 18, 2018
We have never been so fascinated by the secrets inside our cells.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.